Turn Therapeutics Inc. 8-K

What Happened
Turn Therapeutics Inc. (TTRX) filed a Form 8-K on May 11, 2026 (Item 2.02) to announce and furnish a press release reporting its financial and operating results for the quarter ended March 31, 2026. The press release is included as Exhibit 99.1 to the current report. The 8-K itself furnishes the release and does not present additional financial tables in the filing text.

Key Details

• Press release dated May 11, 2026 announcing results for the quarter ended March 31, 2026.
• Filing made under Item 2.02 (Results of Operations and Financial Condition).
• Exhibit 99.1 = Press Release (furnished); Exhibit 104 = Cover Page Interactive Data File (Inline XBRL).
• The Form 8-K furnishes the release; investors should review the press release for line-item figures (revenue, net income/loss, cash position, guidance).

Why It Matters
A furnished press release on quarterly results is a primary source for investors to evaluate Turn Therapeutics’ recent financial performance and cash runway—key factors for biotech companies funding clinical programs. Investors should read the Exhibit 99.1 press release and monitor any subsequent filings (e.g., Form 10-Q) for detailed financial statements and management commentary, which can influence near-term trading and longer-term valuation. This 8-K does not report any executive changes, mergers/acquisitions, or bankruptcy events.